about
MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st CenturyA molecular map of mesenchymal tumors.The Challenges of Detecting Circulating Tumor Cells in SarcomaEGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialGenome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor GeneReexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.Mouse models for cancer stem cell research.Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiencyRecent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA.Predictors of survival in patients with sarcoma admitted to the intensive care unit.Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Benign mesenchymal stromal cells in human sarcomas.Universal marker and detection tool for human sarcoma circulating tumor cells.Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).Do stem-like cells play a role in drug resistance of sarcomas?Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers.Senescence bypass in mesenchymal stem cells: a potential pathogenesis and implications of pro-senescence therapy in sarcomas.The fine needle aspiration of translocation sarcomas.Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.CDK4/6 inhibitors sensitize Rb-positive sarcoma cells to Wee1 kinase inhibition through reversible cell cycle arrest.Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.Targeting the Wnt pathway in synovial sarcoma models.Characterization of three newly established rat sarcoma cell clones.Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2.Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.EGFR expression in circulating tumor cells from high-grade Metastatic Sarcomas.Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?IGF2 is highly expressed in pediatric undifferentiated sarcomas and reveals two distinct cytoplasmic trafficking patterns.Dr. Jekyll and Mr. Hyde: MAP17's up-regulation, a crosspoint in cancer and inflammatory diseases.Paediatric Ewing-like sarcoma arising from the cranium - a unique diagnostic challengePersonalized genomic analysis based on circulating tumor cells of extra-skeletal Ewing sarcoma of the uterus: A case report of a 16-year-old Korean femaleRole of hypoxia inducible factor-1 alpha in modulation of apoptosis resistanceSoft Tissue Sarcoma Cancer Stem Cells: An Overview
P2860
Q24630130-330C1AEB-5038-42EB-8D93-C92C259988F3Q24814030-A6EEFF38-C9FD-4F00-888E-C8DE2011E182Q28078659-41493D20-B00F-48BE-BD3B-195CD0C3E7C5Q28484249-EB741520-FFC8-492D-A081-8F7D814B806FQ28554418-FF37A9E8-960D-4F76-A193-32E5389DD2CFQ33646069-D6533731-2FA0-49EC-BE63-4E8B8EA0E23BQ33684472-0C684A5D-79E6-4CFE-8506-1D690CFC9498Q34254628-9603BA9E-20E5-4EEB-B9A0-F5E14BC95866Q35459525-6F5EE2D6-2C70-4312-AC62-C527388741E0Q35667137-087D2223-EA4D-4B29-B9BE-C535944AAEE2Q36562082-9165F4EA-9844-452E-9D16-DD9823F1B70AQ37106602-9960A23B-FFCA-46C4-A8CB-F60AB25B3493Q37144023-457417DA-2116-4699-BD3A-37B5AB4BF4D0Q37287076-B15BCD9E-40FE-4B03-9605-8DE181330FBCQ37648169-024177AE-F69B-4564-9F70-5AFD3C9659D4Q37687113-54EEED13-EB50-405C-ACAF-20444C150ACDQ37687392-E3DEC199-39CA-43E9-A0F8-9E49BC93EE4AQ37948053-DFBF0870-F500-4383-BF27-DBA7290AFDC5Q38132245-8C5B1421-468B-4703-9E54-BAFADE5B3252Q38373077-51C9159D-FA43-427A-9051-C685F64DFB80Q38625070-45E52FE7-234D-47D4-83E1-EA4C64E7861AQ38723383-CB95636A-2A15-4889-9AB1-4C7BABCFDDA0Q38938230-2BB3841D-EBEA-4BD7-9DA9-90CBDB66D3B8Q39114461-5A1DC59C-53ED-4595-80FC-25DF71AD358FQ39245288-4CD9742C-52C1-4F8E-BD20-57C9E76032D3Q39458600-2B7FB7D2-F676-408D-B25A-BE45049127FBQ40458621-5D1EC85F-CEDF-4E27-802A-3D26AE920356Q47696736-16E16FEC-CFF7-4E14-AB88-C3FA7CB23C2BQ50559927-52A42538-295E-420E-B880-D97C7753F81DQ53162784-86114EC1-26D8-4673-8E80-E23911D71A51Q54474194-2A8A0977-A085-414D-8C95-B49E63D22A54Q55227686-E980BB6B-2F22-47A0-A38C-597071C55912Q56486695-40E8A2A6-5617-4E54-816F-BDEE41960FBDQ57172135-4CB66D7E-F114-449F-8599-831F49E4A9DAQ57243526-082BB7D6-ED8B-42D7-9D58-01C84328815AQ58707604-F9732CDC-2B02-4FF6-9F34-77CF7D78C2A7
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Focus on sarcomas.
@ast
Focus on sarcomas.
@en
Focus on sarcomas.
@nl
type
label
Focus on sarcomas.
@ast
Focus on sarcomas.
@en
Focus on sarcomas.
@nl
prefLabel
Focus on sarcomas.
@ast
Focus on sarcomas.
@en
Focus on sarcomas.
@nl
P2093
P1433
P1476
Focus on sarcomas.
@en
P2093
Crystal L Mackall
Lee J Helman
Paul S Meltzer
P304
P356
10.1016/S1535-6108(02)00132-0
P577
2002-09-01T00:00:00Z